You made this statement: "- However, for hormone-sensitive prostate cancer (HSPC), whether non-metastatic or...
Let me clarify the current state of BAT (Bipolar Androgen Therapy) clinical trials based on authoritative sources:
According to the National Cancer Institute (NCI) clinical trials database and ASCO meeting abstracts:
- For CRPC (Castration-Resistant Prostate Cancer):
- Most studies have been Phase II trials
- The RESTORE and TRANSFORMER trials were key Phase II studies
- There have NOT been completed Phase III trials for BAT in CRPC
- For HSPC (Hormone-Sensitive Prostate Cancer):
- COMBAT-HSPC: A completed Phase II trial
- There is one ongoing Phase II trial currently recruiting
- There have NOT been completed Phase III trials for BAT in HSPC
I apologize for any implication in my previous response that suggested there were Phase III trials for either CRPC or HSPC. To be completely accurate: BAT research for both CRPC and HSPC has primarily been conducted through Phase II trials, with no completed Phase III trials for either condition.
Sources:
- NCI Clinical Trials Database (clinicaltrials.gov)
- ASCO Meeting Library and Guidelines
- Cancer Commons Evidence Summaries
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
- What factors should I consider when deciding whether to pursue active surveillance versus definitive treatment for...
- What is "COMBAT-HSPC"? There is a COMBAT for CRPC. BATMAN was HSPC. So the NCT docs are incorrect for COMBAT? There...
- What is the latest news on bipolar androgen therapy? Are there any completed or upcoming trials for HSPC (either nm...
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 27, 2025. Informational only — not a substitute for your oncology team.
Question asked:
You made this statement: "- However, for hormone-sensitive prostate cancer (HSPC), whether non-metastatic or metastatic, there are currently no completed Phase 3 trials that support BAT use" This implies that there are phase III trials for CRPC. Is that correct? Or are there over a dozen phase II for CRPC and one completed phase II for HSPC and one recruiting HSPC phase II trial?
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- What does progression mean for Prostate Cancer and what happens next
- What are the treatment options for prostate cancer
- What is oligometastatic Prostate Cancer and can it be cured
- What does it mean when Prostate Cancer spreads to the brain
- What causes Prostate Cancer to recur
- When can I drive after Prostate Cancer surgery
- What does lymphovascular invasion mean in Prostate Cancer
- What does indeterminate mean on my Prostate Cancer scan